| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University Department of Endocrinology and Metabolism, University Hospital of Aarhus (J.J., K.S., M.K.), and Department of Cell Biology, Institute of Anatomy, University of Aarhus (L.M.), DK-8000 Aarhus, Denmark; University Hospital of Odense (M.K.), DK-5000 Odense, Denmark; Molecular Medicine Center, Western General Hospital (M.H., J.J.M., J.R.S.), Edinburgh EH4 2XU, Scotland, United Kingdom; and Novartis Pharma AG (J.G.), CH-4057 Basel, Switzerland
Address all correspondence and requests for reprints to: Dr. Moustapha Kassem, University Department of Endocrinology, University Hospital of Odense, DK-5000 Odense, Denmark. E-mail: mkassem{at}dadlnet.dk.
Glucocorticoids (GCs) exert potent, but poorly characterized, effects on the skeleton. The cellular activity of GCs is regulated at a prereceptor level by 11ß-hydroxysteroid dehydrogenases (11ßHSDs). The type 1 isoform, which predominates in bone, functions as a reductase in intact cells and regenerates active cortisol (corticosterone) from circulating inert 11-keto forms. The aim of the present study was to investigate the role of this intracrine activation of GCs on normal bone physiology in vivo using mice deficient in 11ßHSD1 (HSD1-/-). The HSD1-/- mice exhibited no significant changes in cortical or trabecular bone mass compared with wild-type (Wt) mice. Aged HSD1-/- mice showed age-related bone loss similar to that observed in Wt mice. Histomorphometric analysis showed similar bone formation and bone resorption parameters in HSD1-/- and Wt mice. However, examination of bone marrow composition revealed a total absence of marrow adipocytes in HSD1-/- mice. Cells from Wt and HSD1-/- mice exhibited similar growth rates as well as similar levels of production of osteoblastic markers. The adipocyte-forming capacity of in vitro cultured bone marrow stromal cells and trabecular osteoblasts was similar in HSD1-/- and Wt mice. In conclusion, our results suggest that 11ßHSD1 amplification of intracellular GC actions in mice may be required for bone marrow adipocyte formation, but not for bone formation. The clinical relevance of this observation remains to be determined.
This article has been cited by other articles:
![]() |
G. Trudel, M. Payne, B. Madler, N. Ramachandran, M. Lecompte, C. Wade, G. Biolo, S. Blanc, R. Hughson, L. Bear, et al. Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study J Appl Physiol, August 1, 2009; 107(2): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. W. Yau, K. M. McNair, J. Noble, D. Brownstein, C. Hibberd, N. Morton, J. J. Mullins, R. G. M. Morris, S. Cobb, and J. R. Seckl Enhanced Hippocampal Long-Term Potentiation and Spatial Learning in Aged 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Knock-Out Mice J. Neurosci., September 26, 2007; 27(39): 10487 - 10496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grey, M. Bolland, G. Gamble, D. Wattie, A. Horne, J. Davidson, and I. R. Reid The Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Decreases Bone Formation and Bone Mineral Density in Healthy Postmenopausal Women: A Randomized, Controlled Trial J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1305 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Paterson, J. R. Seckl, and J. J. Mullins Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eijken, M. Hewison, M. S. Cooper, F. H. de Jong, H. Chiba, P. M. Stewart, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen 11{beta}-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation Mol. Endocrinol., March 1, 2005; 19(3): 621 - 631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |